key: cord-0751487-yg5r3zue
authors: Santonja, C.; Heras, F.; Núñez, L.; Requena, L.
title: COVID‐19 chilblain‐like lesion: immunohistochemical demonstration of SARS‐CoV‐2 spike protein in blood vessel endothelium and sweat gland epithelium in a PCR‐negative patient
date: 2020-06-25
journal: Br J Dermatol
DOI: 10.1111/bjd.19338
sha: a8b8d9a7c250d0e5512e54302f6e35b868d7753b
doc_id: 751487
cord_uid: yg5r3zue

A 35‐year‐old woman with no significant previous medical history presented at the Emergency Department of Fundación Jiménez Díaz Hospital (Madrid, Spain) on April 14(th) with acral purpuric lesions of three weeks duration. These had started as oedematous, erythematous areas and had appeared coincidentally with fever and coughing, which lasted only two days. There was no history of diarrhoea, ageusia, hyposmia or dyspnea. The patient stated that the skin of her feet acquired a bluish discoloration after standing for some time.

early 2019, biopsies from non-COVID-19 related inflammatory dermatoses and substitution of the antibody with saline serum as negative controls, and a post-mortem lung specimen from a COVID-19 patient as positive control (see inset in Figure 1D ). Perivascular deposits of C5b9, C3 and C1q were seen on direct immunofluorescence study of formalin-fixed, paraffin-embedded tissue. Treatment with low-molecular weight heparin and low-dose aspirin was started; the lesions subsequently healed, and at the time of latest follow-up (June 7 th ) the patient had recovered completely and pedal pulses were palpable. A second serologic study (two months after beginning of the disease), this time by Enzyme-Linked Immunosorbent Assay, was negative for IgG and IgM against SARS-CoV-2.

The ongoing COVID-19 pandemic due to SARS-CoV-2, initially regarded as a primarily pulmonary disorder, has evolved into a multisystemic disease reflecting the tropism of the virus and the inflammatory and thrombotic immunological response.

Cutaneous manifestations of COVID-19 have gained the attention of dermatologists worldwide, and six patterns of involvement have been recognized: urticarial rash, morbilliformmaculopapular, papulovesicular, chilblain-like, livedo reticularis/racemose-like and purpuricvasculitic 1 . Chilblain-like acral lesions are being increasingly reported as possibly related to COVID-19, but a causal relationship is hard to establish, since in many cases (like in ours) no serologic or microbiologic evidence of SARS-CoV-2 infection is detected. This might be due to a swift response from the innate immune system, or to an antibody response different from that of patients without this cutaneous presentation. Nevertheless, systemic or cutaneous endothelial damage might initiate local or systemic thrombotic phenomena, so that involvement of the endothelium is likely to be of pathogenic significance. Other than in respiratory/alveolar epithelial cells or in alveolar macrophages, the virus has been so far identified by electron microscopy and/or immunohistochemistry in lung alveolar capillaries 2 , endothelial cells of kidney glomeruli 3 , brain blood vessels 4 , colonic mucosa 5 and skin 6 

A B C D

Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Endothelial cell infection and endotheliitis in COVID-19

Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)

Accepted Article This article is protected by copyright. All rights reserved

Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD-19 patient with diarrhea

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases

Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways

We would like to thank Sandra Pérez-Buira, PhD, who optimized and